HOME > CONFERENCE > Program details

Keynote Speech (Grand Ballroom 104+105)

  • 10:30 ~ 11:00

    Speaker 1

    Daeje Chin Chairman, Korea Blockchain Association

    Industry 4.0 and Blockchain

  • 11:00 ~ 11:30

    Speaker 2

    Lotta LjungqvistPresident & CEO, GE Nordics

    Technology Trends in Bioprocessing

  • 11:30 ~ 12:00

    Speaker 3

    Muthiah ManoharanSenior Vice President, Alnylam Pharmaceuticals

    RNA Interference (RNAi) Based Therapeutics: From Principles to Patients

Session 1 (Grand Ballroom 104)

AI & New Drug

AI and the Future of Healthcare
Chair_Namkug Kim_Professor, Asan Medical Center
  • 13:30 ~ 13:45

    Chair

    Namkug KimProfessor, Asan Medical Center

    Introductory Speech

  • 13:45 ~ 14:05

    Speaker 1

    Megan HeSenior Director, IQVIA
    Hui JinAssociate Director, IQVIA

    Advanced Analytics and Machine Learning in Healthcare

  • 14:05 ~ 14:30

    Speaker 2

    Maya R.SaidCEO, Outcomes4Me

    AI Innovation for New Drug Development

  • 14:30 ~ 14:50

    Speaker 3

    Sanggoo KangCEO, MedySapiens

    AI trends in bio industry. What should bio industry adapt from IT and AI arena

  • 14:50 ~ 15:10

    Speaker 4

    Tyson KimCEO, Syntekabio

    AI Drug Development in the Era of Precision Medicine.

  • 15:10 ~ 15:35

    Speaker 5

    Andrew RadinCo-Founder,twoXAR

    Partnering in AI-Driven Drug Development

  • 15:35 ~ 16:00

    Q&A

Session 2 (Grand Ballroom 105)

Cell & Gene Therapy

Recent Highlights of Advanced Therapy: Making Dead Cells Work
Chair_BG Rhee_CEO, SCM Lifescience
  • 13:30 ~ 13:35

    Chair

    BG RheeCEO, SCM Lifescience

    Introductory Speech

  • 13:35 ~ 13:50

    Speaker 1

    Patrick Y. LuCEO, Sirnaomics

    Novel siRNA Therapeutics for Immune Oncology Application with Polypeptide Nanoparticle Delivery Technology

  • 13:50 ~ 14:05

    Speaker 2

    Kyeong Eun JungSVP, ST Pharm

    Outlook for Development of Oligonucleotide Therapeutics and Readiness for Commercial Manufacturing.

  • 14:05 ~ 14:20

    Speaker 3

    Dong-ki LeeCEO, OliX

    Asymmetric siRNA Targeting Fibrotic and Ocular Disorders

  • 14:20 ~ 14:35

    Speaker 4

    Han-Oh ParkCEO, BIONEER

    RNAi Nano-drug & SAMiRNA™

  • 14:35 ~ 14:50

    Speaker 5

    Michael NaDirector, ViroMed

    ViroMed and its lead product VM202: Plasmid DNA Gene Therapy Technology and its target indications

  • 14:50 ~ 15:05

    Speaker 6

    Byoung Ok AhnCEO, SL VAXiGEN

    Innovative Gene- and DC-based Vaccine against Cancer and Chronic Infection

  • 15:05 ~ 15:20

    Speaker 7

    Sujeong KimHead, Kolon Life Science

    Kolon Life Science: a leading gene therapy pipeline

  • 15:20 ~ 15:35

    Speaker 8

    Kwang-Won SeoVP, Kangstem Biotech

    Stem cell therapeutics in Atopic dermatitis

  • 15:35 ~ 15:50

    Speaker 9

    Antonio LeeGlobal Head, MEDIPOST

    Commercialization of Advanced Allogeneic Cell Therapy Product in Korea and beyond.

  • 15:50 ~ 16:05

    Speaker 10

    Sun SongCSO, SCM Lifescience

    Clonal Mesenchymal Stem Cell Products for the Treatment of Immune Diseases

Session 3 (Grand Ballroom 101)

Biobased Chemical (Co-organized by KIST-Europe)

Biobased Chemical Industry: The Green Convergence of Industrial Biotechnology and Chemistry Chair
Chair_Jin-Ho Seo_Professor, Seoul National Univ.
  • 13:30 ~ 13:30

    Chair

    Jin-Ho SeoProfessor, Seoul National Univ.

    Introductory Speech

  • 13:30 ~ 13:55

    Speaker 1

    Jens TorslovHead of Projects, Danisch Hydraulic Institute

    EU regulation of medical devices and in-vitro diagnositcs and borderlines to EU REACH

  • 13:55 ~ 14:20

    Speaker 2

    Hyunpyo JeonSenior Researcher, KIST-Europe

    Main issues of EU REACH regulation and compliance strategies

  • 14:20 ~ 14:45

    Speaker 3

    Jin-Sung Ra Principal Researcher, KITECH

    Korean company’s compliance with Act on the Registration and Evaluation of Chemicals and improvements

  • 14:45 ~ 15:10

    Speaker 4

    R. PuvaneswariCEO, MYBiomass

    Biorefinary in Malaysia

  • 15:10 ~ 15:35

    Speaker 5

    Kwang Myung ChoSVP, CJ CheilJedang

    Global Trends in Bio-based Materials and Critical Factors for Successful Market Penetration

  • 15:35 ~ 16:00

    Speaker 6

    In-Joo ChinPresident, Inha Technical College

    Opportunities and Challenges of Biochemical Industry

Session 4 (Grand Ballroom 104)

Microbiome

Microbiome: A New World of Bio-Healthcare Innovations
Chair_Dong Ho Lee_Professor, SNUBH
  • 16:30

    Chair

    Dong Ho LeeProfessor, SNUBH

    Introductory Speech

  • 16:30 ~ 16:45

    Speaker 1

    Hansoo ParkCTO, GENOME & COMPANY

    Microbiome and Precision Medicine

  • 16:45 ~ 17:00

    Speaker 2

    Tae-Wook NamCTO, KOBIOLABS

    Exploit the Microbiome to Treat Diseases

  • 17:00 ~ 17:15

    Speaker 3

    Myoung Ho JangCSO, GI Innovation

    Microbiome with new biologics regulate allergic diseases

  • 17:15 ~ 17:30

    Speaker 4

    Byung-Yong KimResearch Director, ChunLab

    Towards standards for microbiome analysis in human gut study

  • 17:30 ~ 17:45

    Speaker 5

    Jeong Il Lee CEO, J.Young Healthcare

    Influence of PLANT POWERED MEATS on the human microbiome

  • 17:45 ~ 18:00

    Q&A

Session 5 (Grand Ballroom 101)

Gene Editing

Gene Editing: Therapeutic revolution or Biotechnology Innovation?
Chair_Eun Ju Lee_ Professor, SNUH
  • 16:30 ~ 16:35

    Chair

    Eun Ju LeeProfessor, SNUH

    Introductory Speech

  • 16:35 ~ 16:50

    Speaker 1

    Kyung Ae YoonPatent Attorney , Yulchon

    CRISPR/Cas9 Gene Editing Technology: Current Status and Future Prospects

  • 16:50 ~ 17:05

    Speaker 2

    Jungmin LeeHead, ToolGen

    CRISPR/Cas9-mediated generation of next generation CAR-T

  • 17:05 ~ 17:20

    Speaker 3

    Hong Sug KimDirector , Macrogen

    CRISPR system for Precise gene editing in vivo

  • 17:20 ~ 17:35

    Speaker 4

    Sun-Young ChoDept. Manager, Avellino Labs

    Gene therapy for Corneal Dystrophy

  • 17:35 ~ 17:50

    Speaker 5

    Jung-taek KangDirector , MGENPLUS

    Advanced research for generation of genetically engineered pigs using gene editing technology

  • 17:50 ~ 18:00

    Q&A

Session 6 (Grand Ballroom 105)

Brain

Recent Breakthrough in Brain Disorders
Chair_Ae-nim Pae_Chief, KIST
  • 16:30 ~ 16:30

    Chair

    Ae-nim PaeChief, KIST

    Introductory Speech

  • 16:30 ~ 16:50

    Speaker 1

    Ae-nim PaeChief, KIST

    Tau-targeted therapeutic strategy for the treatments of Alzheimer’s disease

  • 16:50 ~ 17:05

    Speaker 2

    Jin Seok JeongSenior Research Fellow, Dong-A ST

    Development of anti-Parkinson’s disease drug in USA

  • 17:05 ~ 17:20

    Speaker 3

    Kiwon LeeCEO, ybrain

    The Stimulated Brain: Recent Trends in Non-invasive Neurostimulation based Therapeutic Medical Devices

  • 17:20 ~ 17:35

    Speaker 4

    Donghyeon KimCTO, NEUROPHET

    Guiding technology for electrical brain stimulation

  • 17:35 ~ 17:50

    Speaker 5

    Youngshik ChoeDepartment Head, Korea Brain Research Institute

    Three dimensional aspects of Alzheimer’s disease

  • 17:50 ~ 18:00

    Q&A